DONG YANG, M.D.
Ophthalmology Physician · OXNARD, CA
Individual Active NPI 1902124076
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,129 | 52,437 | $8,524,781 | $3,413,380 | $2,693,743 |
| 2023 | 689 | 9,209 | $2,242,885 | $1,064,214 | $836,956 |
| 2022 | 186 | 1,224 | $681,706 | $362,796 | $286,747 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 43,020 | $34 | $27 |
| J0177 | Injection, aflibercept hd, 1 mg | 2,080 | $327 | $261 |
| 92134 | Imaging of retina | 2,002 | $46 | $34 |
| 67028 | Injection of drug into eye | 1,128 | $145 | $112 |
| 92014 | Established patient complete exam of visual system | 715 | $143 | $104 |
| J0178 | Injection, aflibercept, 1 mg | 556 | $820 | $652 |
| 92012 | Established patient problem focused exam of visual system | 505 | $102 | $77 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 499 | $17 | $13 |
| J2778 | Injection, ranibizumab, 0.1 mg | 350 | $156 | $124 |
| 92004 | New patient complete exam of visual system | 188 | $168 | $116 |
| 92250 | Photography of the retina | 128 | $41 | $30 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 94 | $220 | $175 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | A120699 | CA |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | A120699 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in California
- NPI 1912094376
- NPI 1740723774
- NPI 1821127770
- NPI 1023161676
- NPI 1417060245
- NPI 1558414193
- NPI 1316961998
- NPI 1508870700
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.